Results for this period
Interim period (second quarter)1 August 2025 to 31 January 2026Non-consolidated (standalone)Japanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
事業収益は前年同期と同じくなし。研究開発費は739,576千円から748,507千円に増加した一方、販売費及び一般管理費は326,504千円から244,410千円に減少し、営業損失は縮小した。
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Non-consolidated (standalone) |
| Period Covered | 1 August 2025 to 31 January 2026 |
| Operating profit | ¥-992 million |
| Ordinary income | ¥-958 million |
| Profit attributable to owners of the parent | ¥-928 million |
| Net income per share | △14.91円 |
| Equity ratio | End of the current fiscal period 74.6% / End of previous period 78.0% |
| Total assets | ¥6,812 million |
| Net assets | ¥6,573 million |
| Cash flows from operating activities | ¥-789,495 thousand |
| Cash flows from investing activities | ¥-1,752,261 thousand |
| Cash flows from financing activities | ¥0 thousand |
| Cash and cash equivalents at end of period | ¥4,452,836 thousand |
| Annual Dividend Forecast | ¥0.00 → ¥0.00 |
| Depreciation and amortization | ¥24,500 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets -, Gain on reversal of subscription rights to shares ¥30,342 thousand / Extraordinary loss Loss on retirement of non-current assets ¥0 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | Yes (for institutional investors and analysts) |
| Issued Shares at Period-End | 62,681,200 shares |
| Treasury Shares at Period-End | 121 shares |
| Factors Behind Changes in Business Performance | 事業収益は前年同期と同じくなし。研究開発費は739,576千円から748,507千円に増加した一方、販売費及び一般管理費は326,504千円から244,410千円に減少し、営業損失は縮小した。 |
Items this document does not state (13)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.事業収益は前年同期と同じくなく、研究開発費は増加した一方、販売費及び一般管理費が減少した。